Maplight Therapeutics Inc (MPLT) Stock Price, Quote & News

Company Profile

MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer's disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spectrum disorder; ML-021 for the treatment of motor deficits in Parkinson's diseas...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 984 6300

Website: www.maplightrx.com

Address:

800 Chesapeake Drive, Redwood City, United States

Duncan_ Jun. 4 at 2:35 PM

$MPLT NOVO holding still their largest tute: https://www.nasdaq.com/market-activity/stocks/mplt/institutional-holdings

2 · Reply

Duncan_ Jun. 4 at 2:26 PM

$MPLT Green on a red day

0 · Reply

Bbboston Jun. 2 at 10:21 PM

$MPLT I don’t like the fact that some insiders have been selling a lot of shares in the last 5-6 weeks. Consistently! I like this company but I am waiting for a chance to open a position. I would very much like to get in at IPO price. 🙃

1 · Reply

Duncan_ May. 27 at 6:35 PM

$MPLT i dont know who blue owl capital is but MPLT is the second largest holding! bold position for any kind of hedge or family fund

0 · Reply

Duncan_ May. 27 at 6:32 PM

$MPLT latest

0 · Reply

Duncan_ May. 19 at 2:57 PM

$MPLT Green on a red day is always nice

0 · Reply

Duncan_ May. 18 at 4:34 PM

$MPLT

0 · Reply

Duncan_ May. 12 at 7:42 PM

$MPLT https://www.nasdaq.com/market-activity/stocks/mplt/institutional-holdings?page=1&rows_per_page=10

1 · Reply

Duncan_ May. 12 at 1:45 PM

$MPLT anyone follow this novo holding company? do we know if they still own MPLT?

2 · Reply

DistributionEquity May. 8 at 8:06 PM

$MPLT Only 110 people watching. Its 45% owned by Sergei Brin's VC firm; It has 3 great looking p2 studies incubating; It is partnered with Googles' quantitative AI company; The share count is low; the cash balance is very high. Someone pinch me. I'm dreaming.

0 · Reply

MapLight Therapeutics price target raised to $36 from $28 at Stifel

2026-05-26T20:27:27.000Z - 13 days ago

MapLight Therapeutics initiated with a Buy at UBS

2026-05-21T12:50:09.000Z - 19 days ago

Craig-Hallum bullish on MapLight Therapeutics, initiates with a Buy

2026-05-21T11:28:49.000Z - 19 days ago

MapLight Therapeutics initiated with a Buy at Craig-Hallum

2026-05-14T20:45:03.000Z - 25 days ago

MapLight Therapeutics reports Q1 EPS ($1.34), consensus ($1.12)

May 14, 2026, 4:05 PM EDT - 25 days ago

MapLight Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

May 14, 2026, 4:00 PM EDT - 25 days ago

MapLight Therapeutics Earnings release: Q1 2026

May 14, 2026, 4:00 PM EDT - 25 days ago

MapLight Therapeutics Quarterly report: Q1 2026

2026-05-14T10:26:57.000Z - 26 days ago

MapLight Therapeutics initiated with an Outperform at LifeSci Capital

2026-05-12T20:10:57.000Z - 27 days ago

MapLight Therapeutics management to meet with Needham

May 8, 2026, 7:00 AM EDT - 4 weeks ago

MapLight Therapeutics to Participate in Upcoming Investor Conferences

2026-05-04T10:16:54.000Z - 5 weeks ago

MapLight Therapeutics initiated with a Buy at H.C. Wainwright

2026-05-01T11:25:19.000Z - 5 weeks ago

MapLight Therapeutics completes enrollment in ZEPHYR trial

May 1, 2026, 7:00 AM EDT - 5 weeks ago

MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

MapLight Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

MapLight Therapeutics Proxy statement: Proxy filing

2026-04-08T09:45:12.000Z - 2 months ago

MapLight Therapeutics initiated with a Buy at Needham

2026-04-07T09:41:31.000Z - 2 months ago

MapLight Therapeutics initiated with a Buy at TD Cowen

Mar 26, 2026, 7:00 AM EDT - 2 months ago

MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Mar 26, 2026, 7:00 AM EDT - 2 months ago

MapLight Therapeutics Annual report: Q4 2025

Mar 26, 2026, 7:00 AM EDT - 2 months ago

MapLight Therapeutics Earnings release: Q4 2025

Mar 26, 2026, 7:00 AM EDT - 2 months ago

MapLight Therapeutics Slides: Corporate presentation

2026-03-19T10:40:48.000Z - 2 months ago

Canaccord starts MapLight with Buy into schizophrenia data

2026-03-19T09:20:13.000Z - 2 months ago

MapLight Therapeutics initiated with a Buy at Canaccord

2026-01-09T12:06:28.000Z - 5 months ago

MapLight Therapeutics expects topline results from ZEPHYR trial in Q3

Jan 9, 2026, 7:00 AM EST - 5 months ago

MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026

Jan 9, 2026, 7:00 AM EST - 5 months ago

MapLight Therapeutics Slides: Corporate Presentation

2026-01-05T12:11:46.000Z - 5 months ago

MapLight Therapeutics receives fast track designation for ML-007C-MA for ADP

Jan 5, 2026, 7:00 AM EST - 5 months ago

MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer's Disease Psychosis

2025-12-16T12:05:49.000Z - 6 months ago

MapLight Therapeutics, SandboxAQ announce strategic collaboration

Dec 16, 2025, 7:00 AM EST - 6 months ago

SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies

2025-12-04T12:05:54.000Z - 6 months ago

MapLight Therapeutics reports Q3 EPS ($37.18) vs ($25.08) last year

Dec 4, 2025, 7:00 AM EST - 6 months ago

MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress

Dec 4, 2025, 7:00 AM EST - 6 months ago

MapLight Therapeutics Quarterly report: Q3 2025

Dec 4, 2025, 7:00 AM EST - 6 months ago

MapLight Therapeutics Earnings release: Q3 2025

Dec 4, 2025, 7:00 AM EST - 6 months ago

MapLight Therapeutics Slides: Corporate Presentation

2025-12-03T16:05:09.000Z - 6 months ago

ADEPT-2 news ‘at face is a win’ for MapLight Therapeutics, says Stifel

BMY

Oct 29, 2025, 9:06 AM EDT - 7 months ago

MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Oct 27, 2025, 11:48 AM EDT - 8 months ago

MapLight Therapeutics valued at $787 million as shares jump in Nasdaq debut

Oct 26, 2025, 5:30 PM EDT - 8 months ago

MapLight Therapeutics Announces Pricing of Initial Public Offering

Oct 6, 2025, 2:00 AM EDT - 8 months ago

MapLight Therapeutics Registration statement: Registration Filing

Sep 19, 2025, 4:11 PM EDT - 9 months ago

MapLight Therapeutics IPO Registration Document (S-1)

Sep 19, 2025, 7:00 AM EDT - 9 months ago

MapLight Therapeutics Registration statement: Registration Filing

Sep 19, 2025, 6:15 AM EDT - 9 months ago

CNS disorder biotech MapLight Therapeutics files for a $100 million IPO

Duncan_ Jun. 4 at 2:35 PM

$MPLT NOVO holding still their largest tute: https://www.nasdaq.com/market-activity/stocks/mplt/institutional-holdings

2 · Reply

Duncan_ Jun. 4 at 2:26 PM

$MPLT Green on a red day

0 · Reply

Bbboston Jun. 2 at 10:21 PM

1 · Reply

Duncan_ May. 27 at 6:35 PM

$MPLT i dont know who blue owl capital is but MPLT is the second largest holding! bold position for any kind of hedge or family fund

0 · Reply

Duncan_ May. 27 at 6:32 PM

$MPLT latest

0 · Reply

Duncan_ May. 19 at 2:57 PM

$MPLT Green on a red day is always nice

0 · Reply

Duncan_ May. 18 at 4:34 PM

$MPLT

0 · Reply

Duncan_ May. 12 at 7:42 PM

$MPLT https://www.nasdaq.com/market-activity/stocks/mplt/institutional-holdings?page=1&rows_per_page=10

1 · Reply

Duncan_ May. 12 at 1:45 PM

$MPLT anyone follow this novo holding company? do we know if they still own MPLT?

2 · Reply

DistributionEquity May. 8 at 8:06 PM

0 · Reply

CH_Expat May. 8 at 6:38 PM

$MPLT Kill it for me and count me in under 20.

0 · Reply

CH_Expat May. 1 at 6:35 PM

$MPLT 106 watchers is the most bullish indicator a biotech stock can possibly have. Your greedy friend never buys at ATH of course. Watchlist. Sexy markets indeed, Phase 1 looks excellent. Cc: @CDMO

1 · Reply

Duncan_ Apr. 29 at 7:25 PM

$MPLT kind of old but interesting:

0 · Reply

History101 Apr. 23 at 2:09 AM

$MPLT 100 watching 4/22/2026

0 · Reply

nlrmandate Apr. 22 at 11:28 PM

$VKTX anyone have any thoughts on $MPLT ? Working on drugs for Alzheimer's, Schizophrenia and ASD.....p1 results looked good and p2 for Schizophrenia and ASD to read out in q3 of this year (Alzheimer's p2 reads out mid-2027). Thinking about a starter position. Thanks in advance! Long VKTX and insanely

1 · Reply

LewisDaKat Apr. 22 at 7:00 PM

$MPLT What a 1% Insider Sale of MPLT Stock Signals Ahead of 2026 Trial Data https://marketwirenews.com/stock/mplt/news/what-a-1-insider-sale-of-mplt-stock-signals-ahead-of-5992050166974582.html?utm_source=stocktwits

0 · Reply